Clinical trial
Zonisamide/Bupropion Effects on Switching to Electronic Cigarettes
NCT04388319 is registered in ClinicalTrials.gov with Rose Research Center, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Zonisamide/Bupropion Effects on Switching to Electronic Cigarettes
- Lead sponsor
- Rose Research Center, LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 27, 2020
- Completion date
- September 15, 2021
- Enrollment
- 26 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
smoking cessation